Detalles de la búsqueda
1.
Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21259918
2.
Efficacy and Safety of a Booster Regimen of Ad26.COV2.S Vaccine against Covid-19
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22270043
3.
Durability of antibody responses elicited by a single dose of Ad26.COV2.S and substantial increase following late boosting
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21262569
4.
Neutralizing antibodies elicited by the Ad26.COV2.S COVID-19 vaccine show reduced activity against 501Y.V2 (B.1.351), despite protection against severe disease by this variant.
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-447722
5.
Safety and immunogenicity of the Ad26.COV2.S COVID-19 vaccine candidate: interim results of a phase 1/2a, double-blind, randomized, placebo-controlled trial
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20199604
6.
SARS-CoV-2 binding and neutralizing antibody levels after vaccination with Ad26.COV2.S predict durable protection in rhesus macaques
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-428921
7.
Ad26-vector based COVID-19 vaccine encoding a prefusion stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-227470
8.
Immunogenicity of an Ad26-based SARS-CoV-2 Omicron Vaccine in Naïve Mice and SARS-CoV-2 Spike Pre-immune Hamsters
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-482636
9.
Ad26.COV2.S elicited neutralizing activity against Delta and other SARS-CoV-2 variants of concern
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-450707
10.
Low-Dose Ad26.COV2.S Protection Against SARS-CoV-2 Challenge in Rhesus Macaques
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-428380
11.
Ad26.COV2.S-elicited immunity protects against G614 spike variant SARS-CoV-2 infection in Syrian hamsters and does not enhance respiratory disease in challenged animals with breakthrough infection after sub-optimal vaccine dosing
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-425915
12.
Immunogenicity of one- and two-dose regimens of the Ad26.COV2.S COVID-19 vaccine candidate in adult and aged rhesus macaques
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-368258
13.
Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22272763
Resultados
1 -
13
de 13
1
Próxima >
>>